News | Clinical Trials | November 21, 2019

Survey finds 1 in 3 Patients Needed More Information on Cancer Treatment Side Effects

Nationwide survey identifies gaps in patient counseling and informed consent processes for radiation therapy, surgery and chemotherapy

One in three adults treated for cancer may experience side effects from treatment they wish they had known more about, according to a new survey published today in the Journal of Oncology Practice

November 21, 2019 — One in three adults treated for cancer may experience side effects from treatment they wish they had known more about, according to a new survey published today in the Journal of Oncology Practice. The national survey of more than 400 U.S. adults, which was sponsored by the American Society for Radiation Oncology (ASTRO), also found that nine in 10 patients felt they made the right treatment decision despite the desire for more information about treatment side effects.

"An unfortunate reality of cancer treatment is that therapy also has side effects that can impact a patient's quality of life. Nearly all patients in the survey felt confident about their treatment decisions, but a sizable number also expressed a clear need for more information about potential side effects," said Reshma Jagsi, M.D., DPhil, FASTRO, senior author of the study and the Newman Family Professor of Radiation Oncology at the University of Michigan.

For each major type of cancer treatment (radiation therapy, chemotherapy, surgery), approximately of one-third of patients experienced treatment-related side effects that they wanted more information about (radiation therapy 37 percent, chemotherapy 36 percent, surgery 34 percent).

Information gaps were related to how severe patients considered their treatment-related side effects to be, with patients who reported severe side effects more likely to say they did not know enough about them. More than a third of patients (38 percent) who reported having severe side effects from cancer treatment also said they felt uninformed, compared to 4 percent of those who reported having minimal side effects.

The survey also looked specifically at patients' experiences with radiation therapy side effects. Patients said these experiences generally were in line with their expectations, although notable numbers felt more tired (29 percent) or weak (28 percent) or experienced worse changes to their energy level (31 percent) than expected.

"More in-depth patient counseling on these side effects could help us better prepare our patients for changes to their quality of life," said Narek Shaverdian, M.D., first author of the study and a radiation oncologist at Memorial Sloan Kettering Cancer Center.

Treatment-related side effects increased with the addition of systemic/drug therapy and/or surgery to a patient's treatment regimen. Fatigue, weakness and pain were significantly more likely to be worse than expected for patients treated with all three modalities, compared to those treated with radiation therapy alone.

"The pronounced impact of treatment side effects for patients receiving combination therapy also suggests a need to build better coordination between oncology disciplines about managing side effects and to improve informed consent processes across cancer therapies," said Shaverdian.

Additional findings from the survey include:

  • The most common side effects patients wished they had known more about with radiation therapy included skin irritation, gastrointestinal (GI) symptoms and fatigue. With chemotherapy, patients wanted more information on nerve damage, GI symptoms and fatigue. With surgery, patients wanted more information on pain, nerve damage and numbness.
  • When rating their experience with treatment-related side effects on a scale from minimal (0) to severe (100), the average ratings were 45 for radiation therapy side effects, 47 for surgery side effects and 63 for chemotherapy side effects.
  • Roughly one in five patients felt they needed more information about possible side effects before they started cancer treatment (radiation therapy: 18 percent, surgery: 20 percent, chemotherapy: 26 percent).
  • The side effects that patients were concerned about most frequently before radiation therapy were feeling tired (56 percent), feeling weak (50 percent) and skin burning (46 percent).
  • A majority of patients (55 percent) consulted their primary care physician (PCP) about cancer treatment options, and 9 in 10 of these said the PCP's advice was very (64 percent) or somewhat (29 percent) important in their decision making.
  • A fourth of all patients surveyed said their PCP was the only information source they consulted. When patients used additional information sources, they were most likely to seek out medical or cancer-related websites, family and friends, the experiences of other patients and cancer support groups.
  • More than two-thirds of patients (68%) perceived their radiation oncologist to have the same or more cancer knowledge as the other oncologists on their treatment team.

Survey Details: An online survey was conducted by Public Opinion Strategies on behalf of ASTRO from March to May 2018 using quota-based sampling to draw a nationwide sample of U.S. adults treated for cancer with radiation therapy within the past five years. A total of 403 respondents completed the survey.

Article Details: "Nationwide survey of patients’ perspectives regarding their radiation and multidisciplinary treatment experiences," published online November 20, 2019 in the Journal of Oncology Practice (https://doi.org/10.1200/JOP.19.00376). Authors include Narek Shaverdian, MD; Debra Yeboa, MD; Liz Gardner, PhD; Paul Harari, MD, FASTRO; Kaiping Liao, PhD; Susan McCloskey, MD, PhD; Richard Tuli, MD, PhD; Neha Vapiwala, MD; and Reshma Jagsi, MD, DPhil, FASTRO.

For more information: www.astro.org

Related Content

Global radiotherapy market revenue is set to expand from $7,222.4 million in 2019 to $17,194.4 million by 2030, at an 8.4% CAGR between 2020 and 2030, the key factor driving the market growth is the increasing number of cancer cases, according to the report published by P&S Intelligence.

Image courtesy of Elekta

News | Radiation Therapy | August 06, 2020
August 6, 2020 — Global ...
Ghost imaging approach could enable detailed movies of the heart with low-dose X-rays

Researchers developed a high-resolution X-ray imaging technique based on ghost imaging that can capture the motion of rapidly moving objects. They used it to create a movie of a blade rotating at 100,000 frames per second. Image courtesy of Sharon Shwartz, Bar-Ilan University

News | X-Ray | August 06, 2020
August 6, 2020 — Researche...
According to the new market research report "Radiation Dose Management Market by Products & Services (Standalone Solutions, Integrated Solutions, Services), Modality (Computed Tomography, Nuclear Medicine), Application (Oncology, Cardiology, Orthopedic), End User (Hospitals) - Global Forecast to 2025", published by MarketsandMarkets, the radiation dose management market is projected to reach USD 422.65 million by 2025 from USD 220.22 million in 2020, at a CAGR of 13.9%.

Courtesy of MarketsandMarkets Research

News | Radiation Dose Management | August 03, 2020
August 3, 2020 — According to the new market research report "...
Siemens AG is continuing to rigorously execute its Vision 2020+ strategy and therefore expressly welcomes Siemens Healthineers AG’s acquisition of a 100 percent stake in Varian Medical Systems, Inc., a U.S. company active in the area of cancer research and therapy.

Getty Images

News | Radiology Business | August 03, 2020
August 3, 2020 — Siemens AG is continuing to rigorously execute its Vision 2020+ strategy and therefore expressly wel
JAMA Oncol. Published online  July 30, 2020. doi:10.1001/jamaoncol.2020.2783

Table 1. JAMA Oncol. Published online  July 30, 2020. doi:10.1001/jamaoncol.2020.2783

News | Coronavirus (COVID-19) | July 31, 2020
July 31, 2020 — An article published in JAMA...
Older Americans may be receiving cancer screenings not recommended by the U.S. Preventive Services Task Force, according to Penn State College of Medicine researchers.

Getty Images

News | Radiology Imaging | July 31, 2020
July 31, 2020 — Older Americans may be receiving cancer screenings not recommended by the...
It has been estimated that the overwhelming focus on COVID-19 could cause up to 35,000 excess cancer deaths in the UK during the next 12 months, and  Zegami, the Oxford University data visualization spin-out which has worked on several projects focused on the detection, diagnosis, or management of cancer, is calling for greater use of technology to speed up the process of diagnosis and treatment.

Getty Images

News | Radiation Oncology | July 29, 2020
July 29, 2020 — It has been estimated that the overwhelming focus on...
Prostate biopsy with cancer probability (blue is low, red is high). This case was originally diagnosed as benign but changed to cancer upon further review. The AI accurately detected cancer in this tricky case. Image courtesy of Ibex Medical Analytics

Prostate biopsy with cancer probability (blue is low, red is high). This case was originally diagnosed as benign but changed to cancer upon further review. The AI accurately detected cancer in this tricky case. Image courtesy of Ibex Medical Analytics

News | Prostate Cancer | July 28, 2020
July 28, 2020 — A study published in